CROSBY Research – Pentamaster International (1665 HK/BUY): Steady 3Q23 revenue growth driven by medical devices segment; demand for automotive segment may slowdown in 4Q23

09 Nov 2023

Pentamaster’s 3Q23 revenue increased 16.1% YoY from MYR155.6m in 3Q22 to MYR180.7m. Automated Test Equipment (ATE) segment revenue declined 3.3% YoY to MYR98.6m due to longer project lead time and revenue recognition varied quarter by quarter. Factory Automation Solutions (FAS) segment revenue surged 53.0% YoY to MYR82.1m on wider acceptance of factory automation, and growing demand for medical devices industry. GPM narrowed 0.8ppt YoY to 30.5% in 3Q23 on labor and raw material cost inflationary pressure. Net profit was MYR36.5m in 3Q23, up 12.5% YoY.